Anti-Human ACVRL1 Therapeutic Antibody (Ascrinvacumab)

Recombinant monoclonal antibody to ACVRL1. Ascrinvacumab is a human monoclonal antibody that can be potentially used in the treatment of Mesothelioma, pleural malignant, Hepatocellular carcinoma (HCC).
Supplier Creative Biolabs
Product # TAB-003ML
Pricing Inquiry
Host Human
Target ACVRL1
Species Reactivity Human
Type IgG2, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback